The discovery of two forms of secondary hypertension in the same patient is unusual and suggests similar pathophysiological mechanisms, a predisposition to one type in the presence of the other or a chance occurrence. We describe two patients with renal artery stenosis who after successful correction of the stenotic lesions were discovered to have primary hyperaldosteronism associated with bilateral adrenal hyperplasia. Initially prior to revascularisation of the renal artery stenosis, the diagnosis of primary hyperaldosteronism was not evident. Both patients were subjected to further
Introduction
Secondary forms of hypertension are important because they represent potentially curable disorders. Two types frequently considered in patients with resistant hypertension are renovascular hypertension due to renal artery stenosis and primary hyperaldosteronism due to an adenoma or bilateral adrenal hyperplasia. Both forms of secondary hypertension are found in less than 2% of all hypertensive subjects. 1 These two types of secondary hypertension involve abnormalities in the renin-angiotensinaldosterone systems which perpetuate the hypertension; both disorders are associated with increased aldosterone production but have opposing effects on plasma renin activity. Hypokalaemia can be a clinical clue for the presence of primary hyperaldosteronism and is seen in 50-60% of patients with hyperaldosteronism 2 as well as 15-20% of cases of renovascular hypertension. 3 In renovascular hypertension, correction of the stenotic lesion usually results in normalisation of the serum potassium levels. 4 Similarly in primary hyperaldosteronism, either removal of an adenoma or treatment with spironolactone corrects hypokalaemia.
On a theoretical basis, tertiary hyperaldosteronism has been suggested as a long term consequence of prolonged adrenal mineralocorticoid stimulation in renovascular hypertension. 5 The existence of tertiary hyperaldosteronism has however been strongly diagnostic evaluation after the appearance of hypokalaemia in one patient and continued resistant hypertension in both patients. The addition of spironolactone therapy reduced blood pressure impressively in both patients. Clinicians should be aware of the possibility that these two forms of secondary hypertension may be present in the same patient and that optimal blood pressure control requires diagnostic assessment and intervention for both disorders. Journal of Human Hypertension (2000) 14, 151-153 challenged by Conn and colleagues who reviewed five cases of primary reninism associated with juxtaglomerular tumours. 6 They noted that two patients had been exposed to prolonged hyperreninaemia for many years and that after surgical intervention, both showed a decline in aldosterone excretion. They recommended that the term 'tertiary' hyperaldosteronism be abandoned.
In this brief report, we describe two hypertensive patients who, after correction of atherosclerotic renal artery stenosis, continued to have resistant hypertension and/or developed hypokalaemia. After further investigation, they were both diagnosed with biochemical evidence for hyperaldosteronism associated with bilateral adrenal hyperplasia on CT scan. Spironolactone therapy resulted in marked reductions in blood pressure and normalisation of serum potassium levels. Our two cases and previous reports [7] [8] [9] [10] [11] [12] [13] [14] suggest that clinicians should be aware that the two conditions may coexist in the same patient and that primary hyperaldosteronism may be an aetiology of resistant hypertension and/or hypokalaemia after revascularisation of renal artery stenosis.
Case reports

Case 1
A 73-year-old man with peripheral vascular disease was referred to the Section of Hypertension and Clinical Pharmacology by his primary care physician for evaluation of resistant hypertension. Hypertension that had been controlled for 40 years became increasingly elevated, despite combination drug therapy (nifedipine GITS 120 mg daily, transdermal clonidine 0.2 mg/day, furosemide 20 mg daily and potassium chloride 20 meq/day). There were no symptoms or signs to suggest catecholamine excess, thyroid disease or Cushing's syndrome.
On initial examination, blood pressure was 170/110 mm Hg without arm disparity or postural blood pressure changes. Resolving haemorrhages were noted on retinal exam. There were no signs of congestive heart failure or acute target organ injury, although a 4th heart sound was audible. A systolic abdominal bruit was heard in the epigastric area and pedal and posterior tibial pulses were diminished.
Initial laboratory data showed a serum potassium of 3.3 mEq/L and a serum creatinine of 1.6 mg/dl. Both supine aldosterone concentration and plasma renin activity were elevated at 27 ng/dl (normal 4 -8 ng/dl) and 9.8 ng/ml/h (normal 0.5-1.6 ng/ml/h) respectively. Renal angiography demonstrated an 80-90% non-ostial stenosis of the proximal left renal artery with post-stenotic dilatation. The right renal artery was angiographically normal. Percutaneous transluminal angioplasty (PTRA) was performed successfully without complications. The patient remained on amlodipine 10 mg daily. Blood pressure declined to 160-170/100-108 mm Hg 4 weeks post-angioplasty. An ambulatory blood pressure study post-angiography showed the 24-h average to be 156/89 mm Hg, awake average blood pressure of 162/97 mm Hg, and sleep blood pressure of 141/66 mm Hg. However, hypokalaemia persisted (ranging from 3.0-3.3 meq/L) and office blood pressure remained elevated. A follow-up renal scan with 99m Tc mercaptoacetylglycine (MAG-3) showed no evidence of restenosis. Repeated supine aldosterone was 21 ng/dl and 53.7 ng/dl and plasma renin activity was 2.4 ng/ml/h and 4.6 ng/ml/h respectively.
Computerised tomography showed enlarged adrenal glands without a discrete adenoma. The patient refused adrenal vein sampling and spironolactone 50 mg twice daily was initiated empirically. His blood pressure declined to 130/80 mm Hg within 4 to 8 weeks. The patient remained normokalaemic (serum potassium over 3.6 meq/L) with average blood pressure around 130-140/80-84 mm Hg over 2 years (Table 1) . Repeat 24-h ambulatory blood pressure monitoring while taking amlodipine 10 mg daily and spironolactone 50 mg b.i.d. showed 24-h blood pressure to be 141/83 mm Hg, awake of 145/86 mm Hg, and sleep blood pressure of 130/76 mm Hg.
Case 2
A 76-year-old woman with a 35-year history of hypertension was referred for evaluation of refrac- Carotid bruits were present bilaterally. Cardiopulmonary exam was significant for an S4 and a systolic abdominal bruit was heard. A dynamic renal study performed after the intravenous injection of 10.9 mCi of 99m Tc MAG-3 showed a 9 cm size right kidney contributing only 30% of total renal function. Renal angiography showed bilateral renal artery stenosis, an ostial lesion of the right renal artery and a high grade (Ͼ90%) eccentric proximal lesion of the left renal artery. The patient underwent bilateral iliac-renal bypass using a reverse y-graft without complications. Despite successful revascularisation, blood pressure remained in the 160-184/100-110 mm Hg range during the next few months while on multiple drug regimens. Serum potassium ranged from 2.7 to 3.2 meq/L while the patient was taking losartan 50 mg twice daily, furosemide 40 mg daily, and labetalol 200 mg twice daily. Supine serum aldosterone and plasma renin activity were 29 ng/dl and 0.3 ng/ml/h respectively after surgery while taking all the above medications. Computerised tomography of the adrenal glands showed diffuse bilateral adrenal enlargement with no distinct masses. The patient also refused adrenal veins sampling and spironolactone 25 mg twice daily was commenced. Blood pressure declined to 150-160/80-84 mm Hg and serum potassium remained above 3.6 meq/L (Table 1) .
One year later the patient has a skin eruption and she discontinued her spironolactone. On her next visit to the clinic some 4 weeks later her blood pressure was 196/102 mm Hg. She was restarted on spironolactone with an impressive reduction of blood pressure to 130/76 mm Hg after 8 weeks. She remains well controlled (office blood pressure Ͻ140/90 mm Hg) on her drug combination.
Discussion
Revascularisation of atherosclerotic renal artery stenosis either surgically or by angioplasty results in only a very small percentage of patients who are normotensive without antihypertensive therapy. 15 It is therefore not unusual for hypertension to persist after revascularisation. Fortunately, most patients have improved blood pressure control on fewer medications. Therefore, while the continued presence of elevated blood pressure is likely, the appear-ance or persistence of hypokalaemia and continued refractory hypertension is unexpected after correction of the stenosis. 4 While hypokalaemia is seen in 16% of patients with renovascular hypertension, this biochemical abnormality usually normalises after amelioration of the stenosis. 3 The presence of hypokalaemia and/or relatively resistant hypertension following correction of renal artery stenosis led to further evaluation of our two patients resulting in the diagnosis of primary hyperaldosteronism associated with bilateral adrenal hyperplasia. In both patients, spironolactone therapy in addition to other antihypertensives resulted in impressive reductions in blood pressure and normalisation of serum potassium levels.
The use of aldosterone and renin in the diagnosis of primary hyperaldosteronism can be problematic in patients with established renovascular disease who may have large and small vessel kidney disease. Furthermore, the presence of mild renal insufficiency in our two patients would make the measured renin levels somewhat higher than expected. Therefore the lack of suppressed renin in patient 1 did not discourage us from considering the diagnosis. The impressive blood pressure response to spironolactone in both cases and the marked elevation of blood pressure when patient 2 discontinued spironolactone and the subsequent response on restarting it, is strong clinical evidence of the disorder in both cases.
The important clinical clues in our patients and several reported cases are (a) hypokalaemia and/or (b) continued resistant hypertension after correction of renal artery stenosis. It is prudent to assess the patency of revascularisation in such patients prior to considering a second cause of hypertension.
Other authors have also reported the simultaneous diagnosis of renovascular and primary hyperaldosteronism. [7] [8] [9] [10] [11] [12] [13] [14] However, most of the cases have described the coexistence of an aldosteronoma with renovascular hypertension; only one case described unilateral adrenal hyperplasia. Complete exclusion of a small adrenal adenoma (Ͻ1.0 cm) in our two patients is not possible because they both refused adrenal vein sampling and computerised axial tomography of the adrenal glands only has about an 80% sensitivity for adenomas. 15 Our two cases do not provide any additional evidence on whether prolonged secondary hyperaldosteronism may transform into tertiary or autonomous adrenal hyperplasia. 5 Unfortunately no experimental studies can be quoted against or for such a proposition. Prior authors have suggested that this terminology be abandoned and objected on a pathophysiological basis for its existence. 6 In one study of 136 cases of primary hyperaldosteronism, 11 10 patients (7%) were discovered to have renal artery stenosis. Nevertheless, routine screening of all patients with renal artery stenosis for primary hyperaldosteronism or vice versa cannot be recommended at this time.
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In summary, these two cases illustrate that both primary hyperaldosteronism and renovascular hypertension may rarely occur in the same patient. The clinical clues to the presence of hyperaldosteronism in our patients who have correction of renal artery stenosis are new or persistent hypokalaemia and continued resistant hypertension. It is noteworthy that either disorder may be initially discovered although renal artery stenosis was discovered initially in our patients. Alternatively, patients may have primary aldosteronism treated initially with a poor result which may cause a search for other causes of secondary hypertension. Clinical suspicion is paramount to detect these rare cases of double causation of secondary hypertension.
